The number of deals announced in the global healthcare sector (including pharmaceuticals and medical equipment) declined by 12% during the week ended June 28, 2020 compared to the previous week, according to GlobalData’s deals database.

Aurojyoti Bose, Lead Analyst at GlobalData, comments: “Though the healthcare sector has been relatively resilient compared to other sectors amid uncertainty and volatile market conditions due to the COVID-19 outbreak, deal activity in the sector has been inconsistent during the last few weeks and this is the second consecutive week of decline in deal activity.”

Deal activity has also remained inconsistent across geographies since the COVID-19 outbreak. While deal activity decreased in key markets such as the US, China, the UK and Canada during the week ended June 28, 2020 compared to the previous week, Japan and Australia witnessed growth.

Mergers and acquisitions (M&A), private equity, partnership and licensing agreement deals volume decreased by 16.7%, 44.4%, 32.6% and 18.2%, respectively, during the week ended June 28, 2020 compared to the previous week, while the number of equity offering and venture financing deals increased by 23.4% and 17.2%, respectively.